Literature DB >> 2318746

Effect of different carbohydrates on growth, polysaccharidase and glycosidase production by Bacteroides ovatus, in batch and continuous culture.

G T Macfarlane1, S Hay, S Macfarlane, G R Gibson.   

Abstract

Bacteroides ovatus was grown in batch culture on 12 different carbon sources (five polysaccharides, seven monosaccharides and disaccharides). Specific growth rates were determined for each substrate together with polysaccharidase and glycosidase activities. Growth rates on polymerized carbohydrates were as fast or faster than on corresponding simple sugars, demonstrating that the rate of polysaccharide depolymerization was not a factor limiting growth. Bacteroides ovatus synthesized a large range of polymer-degrading enzymes. These polysaccharidases and glycosidases were generally repressed during growth on simple sugars, but arabinose was required for optimal production of alpha-arabinofuranosidase. Polysaccharidase and glycosidase activities were measured in continuous cultures grown with either xylan or guar gum under putative carbon limitation. With the exception of beta-xylosidase, activities of the polymer-degrading enzymes were inversely related to growth rate. This correlated with polysaccharide utilization which was greatest at low dilution rates. These results show that Bact. ovatus is highly adapted for growth on polymerized carbohydrate in the human colon and confirm that the utilization of polysaccharides is partly regulated at the level of enzyme synthesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2318746     DOI: 10.1111/j.1365-2672.1990.tb02564.x

Source DB:  PubMed          Journal:  J Appl Bacteriol        ISSN: 0021-8847


  25 in total

1.  Immobilization of infant fecal microbiota and utilization in an in vitro colonic fermentation model.

Authors:  C Cinquin; G Le Blay; I Fliss; C Lacroix
Journal:  Microb Ecol       Date:  2004-04-19       Impact factor: 4.552

2.  Co-utilization of polymerized carbon sources by Bacteroides ovatus grown in a two-stage continuous culture system.

Authors:  G T MacFarlane; G R Gibson
Journal:  Appl Environ Microbiol       Date:  1991-01       Impact factor: 4.792

3.  Effect of pH and antibiotics on microbial overgrowth in the stomachs and duodena of patients undergoing percutaneous endoscopic gastrostomy feeding.

Authors:  Graeme A O'May; Nigel Reynolds; Aileen R Smith; Aileen Kennedy; George T Macfarlane
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

4.  Composition and metabolic activities of bacterial biofilms colonizing food residues in the human gut.

Authors:  Sandra Macfarlane; George T Macfarlane
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

5.  The use of scintigraphy to provide "proof of concept" for novel polysaccharide preparations designed for colonic drug delivery.

Authors:  D A Adkin; C J Kenyon; E I Lerner; I Landau; E Strauss; D Caron; A Penhasi; A Rubinstein; I R Wilding
Journal:  Pharm Res       Date:  1997-01       Impact factor: 4.200

6.  Formulation and physicochemical characterization of buccoadhesive microspheres containing diclofenac sodium.

Authors:  Mitra Jelvehgari; Hadi Valizadeh; Ramin Jalali Motlagh; Hassan Montazam
Journal:  Adv Pharm Bull       Date:  2014-02-07

7.  Expression and characterization of a Bifidobacterium adolescentis beta-mannanase carrying mannan-binding and cell association motifs.

Authors:  Evelina Kulcinskaja; Anna Rosengren; Romany Ibrahim; Katarína Kolenová; Henrik Stålbrand
Journal:  Appl Environ Microbiol       Date:  2012-10-12       Impact factor: 4.792

Review 8.  Microbial biofilms and gastrointestinal diseases.

Authors:  Erik C von Rosenvinge; Graeme A O'May; Sandra Macfarlane; George T Macfarlane; Mark E Shirtliff
Journal:  Pathog Dis       Date:  2013-01-29       Impact factor: 3.166

9.  Effect of pH on an in vitro model of gastric microbiota in enteral nutrition patients.

Authors:  Graeme A O'May; Nigel Reynolds; George T Macfarlane
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

10.  Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response.

Authors:  E Furrie; S Macfarlane; J H Cummings; G T Macfarlane
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.